A novel catheter for very high-power short-duration ablation for pulmonary vein isolation reduced procedure time with similar atrial fibrillation/atrial tachycardia recurrence at 1 year vs. standard ablation, researchers reported.
In addition, rates of successful first-pass ablation and adverse events were similar between the very high-power short-duration ablation arm and the control arm, according to the results of the FAST AND FURIOUS PVI study published in EP Europace.
“In this study we evaluated the safety and efficacy of very high-power short-duration ablation for pulmonary vein